Annual report

Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 146
MetricValuePeriodScopeSource row
Revenue¥6.3bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥6.1bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥5.0bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Revenue¥11.3bn2021-01-01 → 2021-12-31dCons.Net sales (5-year summary)
Revenue¥17.6bn2020-01-01 → 2020-12-31dCons.Net sales (5-year summary)
Operating income¥629m2024-01-01 → 2024-12-31Cons.Operating income
Operating income−¥1.0bn2023-01-01 → 2023-12-31Cons.Operating income
Ordinary income¥688m2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥3.4bn2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income−¥6.1bn2021-01-01 → 2021-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥5.5bn2020-01-01 → 2020-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥565m2024-01-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥3.6bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥898m2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥3.6bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥4.9bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥9.6bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.9bn2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥898m2024-01-01 → 2024-12-31Cons.Profit loss
Net income−¥3.6bn2023-01-01 → 2023-12-31Cons.Profit loss
Total assets¥12.9bnat 2024-12-31Cons.Assets
Total assets¥13.2bnat 2023-12-31Cons.Assets
Total assets¥15.0bnat 2022-12-31dCons.Total assets (5-year summary)
Total assets¥22.5bnat 2021-12-31dCons.Total assets (5-year summary)
Total assets¥31.8bnat 2020-12-31dCons.Total assets (5-year summary)
Total liabilities¥4.9bnat 2024-12-31Cons.Liabilities
Total liabilities¥6.5bnat 2023-12-31Cons.Liabilities
Net assets / equity¥8.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.0bnat 2022-12-31dCons.Net assets
Net assets / equity¥12.8bnat 2021-12-31dCons.Net assets (5-year summary)
Net assets / equity¥22.8bnat 2020-12-31dCons.Net assets (5-year summary)
Cash and deposits¥4.5bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥4.5bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.2bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2022-12-31dCons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2021-12-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥4.7bnat 2020-12-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥362m2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥307m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥2.0bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.6bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥5m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥1.2bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥190m2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.6bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.8bn2020-01-01 → 2020-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.2bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥1.5bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥997m2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.0bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥649m2020-01-01 → 2020-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥17.92024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-76.252023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-112.262022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-220.522021-01-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.182020-01-01 → 2020-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.822020-01-01 → 2020-12-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥158.67at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥134.93at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥184.6at 2022-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥293.88at 2021-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥525.83at 2020-12-31dCons.Net assets per share (5-year summary)
Equity ratio61.7%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio53.5%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio56.8%at 2021-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio71.7%at 2020-12-31dCons.Equity to asset ratio (5-year summary)
ROE12.2%2024-01-01 → 2024-12-31Cons.Rate of return on equity (5-year summary)
ROE-48.9%2023-01-01 → 2023-12-31Cons.Rate of return on equity (5-year summary)
ROE-47.0%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
ROE-53.9%2021-01-01 → 2021-12-31dCons.Rate of return on equity (5-year summary)
ROE18.3%2020-01-01 → 2020-12-31dCons.Rate of return on equity (5-year summary)
Employees214at 2024-12-31Cons.Number of employees
Employees208at 2023-12-31Cons.Number of employees
Employees210at 2022-12-31dCons.Number of employees
Employees264at 2021-12-31dCons.Number of employees
Employees274at 2020-12-31dCons.Number of employees
Revenue¥5.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.4bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥4.6bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥10.6bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥17.1bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥501m2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥1.0bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥947m2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥3.3bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥5.9bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.5bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥829m2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥3.7bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥1.2bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥3.7bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥5.0bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income−¥9.3bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.9bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥12.1bnat 2024-12-31StandaloneAssets
Total assets¥12.2bnat 2023-12-31StandaloneAssets
Total assets¥14.3bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥21.9bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥31.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥4.7bnat 2024-12-31StandaloneLiabilities
Total liabilities¥6.2bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥7.4bnat 2024-12-31StandaloneNet assets
Net assets / equity¥6.0bnat 2023-12-31StandaloneNet assets
Net assets / equity¥7.5bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥12.4bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥22.2bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.5bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥4.1bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥23.342024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-78.632023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-113.642022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-213.032021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥89.572020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥89.212020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥252020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥147.67at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥120.52at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥171.91at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥284.83at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥512.14at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio61.1%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio52.4%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio56.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.6%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE17.4%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE-55.1%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE-49.8%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE-53.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE18.9%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued50,636,900at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued50,436,900at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued44,136,900at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued44,136,900at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued44,001,900at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees186at 2024-12-31StandaloneNumber of employees
Employees178at 2023-12-31StandaloneNumber of employees
Employees175at 2022-12-31dStandaloneNumber of employees
Employees226at 2021-12-31dStandaloneNumber of employees
Employees237at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 58
SegmentItemPeriodValue
Otherother segmentsrevenue2024-01-01 → 2024-12-31¥5m
Otherother segmentsrevenue external2024-01-01 → 2024-12-31¥5m
Otherother segmentssegment assetsat 2024-12-31¥13m
Otherother segmentssegment profit2024-01-01 → 2024-12-31−¥12m
Reconciling Itemsreconcilingcapex2024-01-01 → 2024-12-31¥67m
Reconciling Itemsreconcilingdepreciation2024-01-01 → 2024-12-31¥24m
Reconciling Itemsreconcilingsegment assetsat 2024-12-31¥5.8bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥837m
Infection Control Businessreportable segmentcapex2024-01-01 → 2024-12-31¥4m
Infection Control Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥12m
Infection Control Businessreportable segmentemployeesat 2024-12-3144 pure
Infection Control Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥508m
Infection Control Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥508m
Infection Control Businessreportable segmentsegment assetsat 2024-12-31¥710m
Infection Control Businessreportable segmentsegment profit2024-01-01 → 2024-12-31−¥467m
Pharmaceuticals Businessreportable segmentcapex2024-01-01 → 2024-12-31¥137m
Pharmaceuticals Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥220m
Pharmaceuticals Businessreportable segmentemployeesat 2024-12-31143 pure
Pharmaceuticals Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentsegment assetsat 2024-12-31¥6.3bn
Pharmaceuticals Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥1.9bn
—segment totalemployeesat 2024-12-31187 pure
Total Of Reportable Segments And Otherssegment totalcapex2024-01-01 → 2024-12-31¥142m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-01-01 → 2024-12-31¥232m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-12-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-12-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-12-31¥7.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-12-31¥1.5bn
Otherother segmentsrevenue2023-01-01 → 2023-12-31¥5m
Otherother segmentsrevenue external2023-01-01 → 2023-12-31¥5m
Otherother segmentssegment assetsat 2023-12-31¥12m
Otherother segmentssegment profit2023-01-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingcapex2023-01-01 → 2023-12-31¥68m
Reconciling Itemsreconcilingdepreciation2023-01-01 → 2023-12-31¥135m
Reconciling Itemsreconcilingsegment assetsat 2023-12-31¥6.5bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥996m
Infection Control Businessreportable segmentcapex2023-01-01 → 2023-12-31¥89m
Infection Control Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥44m
Infection Control Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥929m
Infection Control Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥929m
Infection Control Businessreportable segmentsegment assetsat 2023-12-31¥823m
Infection Control Businessreportable segmentsegment profit2023-01-01 → 2023-12-31−¥1.2bn
Pharmaceuticals Businessreportable segmentcapex2023-01-01 → 2023-12-31¥101m
Pharmaceuticals Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥525m
Pharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥5.2bn
Pharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥5.2bn
Pharmaceuticals Businessreportable segmentsegment assetsat 2023-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalcapex2023-01-01 → 2023-12-31¥190m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-01-01 → 2023-12-31¥569m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-12-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-12-31−¥8m
Infection Control Businessreportable segmentemployeesat 2024-12-3137 pure
Pharmaceuticals Businessreportable segmentemployeesat 2024-12-31122 pure
—segment totalemployeesat 2024-12-31159 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,550
ItemContextValueUnit
Subscription rights to sharesCurrentYearInstant-JPY
Net assetsPrior1YearInstant6739000000JPY
Net assetsCurrentYearInstant7964000000JPY
Liabilities and net assetsPrior1YearInstant13220000000JPY
Liabilities and net assetsCurrentYearInstant12914000000JPY
Net salesPrior1YearDuration6120000000JPY
Net salesCurrentYearDuration6292000000JPY
Cost of salesPrior1YearDuration3543000000JPY
Cost of salesCurrentYearDuration2626000000JPY
Gross profitPrior1YearDuration2577000000JPY
Gross profitCurrentYearDuration3666000000JPY
Selling general and administrative expensesPrior1YearDuration3583000000JPY
Selling general and administrative expensesCurrentYearDuration3036000000JPY
Operating incomePrior1YearDuration-1005000000JPY
Operating incomeCurrentYearDuration629000000JPY
Interest income noiPrior1YearDuration25000000JPY
Interest income noiCurrentYearDuration30000000JPY
Foreign exchange gains noiPrior1YearDuration31000000JPY
Foreign exchange gains noiCurrentYearDuration39000000JPY
Restoration contribution income noiPrior1YearDuration9000000JPY
Restoration contribution income noiCurrentYearDuration-JPY
Other noiPrior1YearDuration15000000JPY
Other noiCurrentYearDuration16000000JPY
Non operating incomePrior1YearDuration82000000JPY
Non operating incomeCurrentYearDuration86000000JPY
Interest expenses noePrior1YearDuration8000000JPY
Interest expenses noeCurrentYearDuration8000000JPY
Rent expenses noePrior1YearDuration1000000JPY
Rent expenses noeCurrentYearDuration4000000JPY
Plant shutsdown related costs noePrior1YearDuration291000000JPY
Plant shutsdown related costs noeCurrentYearDuration-JPY
Commission fee noePrior1YearDuration15000000JPY
Commission fee noeCurrentYearDuration12000000JPY
Other noePrior1YearDuration9000000JPY
Other noeCurrentYearDuration2000000JPY
Non operating expensesPrior1YearDuration325000000JPY
Non operating expensesCurrentYearDuration28000000JPY
Ordinary incomePrior1YearDuration-1248000000JPY
Ordinary incomeCurrentYearDuration688000000JPY
Gain on sales of noncurrent assets eiPrior1YearDuration76000000JPY
Gain on sales of noncurrent assets eiCurrentYearDuration-JPY
Gain on sales of investment securities eiPrior1YearDuration221000000JPY
Gain on sales of investment securities eiCurrentYearDuration10000000JPY
Compensation income eiPrior1YearDuration-JPY
Compensation income eiCurrentYearDuration200000000JPY
Extraordinary incomePrior1YearDuration298000000JPY
Extraordinary incomeCurrentYearDuration210000000JPY
Loss on sales of noncurrent assets elPrior1YearDuration0JPY
Loss on sales of noncurrent assets elCurrentYearDuration-JPY
Loss on retirement of noncurrent assets elPrior1YearDuration4000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass